Skip to main content
NIH funding notice RFA-NS-24-010

Early-Stage Therapy Development for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed)

Closed on September 8, 2023.

Posted
May 15, 2023
Close date
September 8, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$655,638
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF DENVER (COLORADO SEMINARY)1

Most frequent study sections

  1. Special Emphasis Panel (ZNS1 SRB-M (19))1
1 award under RFA-NS-24-010 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2024Synthetic protein mimetics as potential therapeutics for Lewy Body Dementia1R61NS137824-01Kumar, SunilUNIVERSITY OF DENVER (COLORADO SEMINARY), COFirst-year cost $655,638Study section ZNS1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.1.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-NS-24-010: Early-Stage Therapy Development for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed) | ScienceDex | ConductScience